Amgen, Inc.
Biotech company announces offer of $2B in two series of senior notes
Published in Lab Business Week, December 26th, 2004
The offering is being made pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended. The sale of the notes is expected to close on November 18, 2004, subject to customary closing conditions.
Amgen estimates that the net proceeds from the offering of the notes will be approximately $1.99 billion after deducting fees and expenses. Amgen intends to use the net proceeds of the offering primarily for open market purchases of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2004-12-26)
More Articles from Lab Business Week
- Acambis plc
Pharma company releases third quarter 2004 results - Access Pharmaceuticals, Inc.
Pharmaceutical company reports loss of $0.16 per share - Alchemia Limited
Pharma company discusses financial results - Antares Pharma, Inc.
Pharmaceutical firm reports loss of $0.06 per share - Astralis, Ltd.
Biotech company reports loss of $0.02 per share - Australian Cancer Technology
Australian biotech firm confirms fundraising - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
